Diabetes reviews (Alexandria, Va.)

Differences in the Association of Select Dietary Measures With Risk of Incident Type 2 Diabetes.  45:2602-2610. 2022

Relation Of Change or Substitution of Low- and No-Calorie Sweetened Beverages With Cardiometabolic Outcomes: A Systematic Review and Meta-Analysis of Prospective Cohort Studies.  45:1917-1930. 2022

Weight Change During the Postintervention Follow-up of Look AHEAD.  45:1306-1314. 2022

Neighborhood Socioeconomic Environment and Risk of Type 2 Diabetes: Associations and Mediation Through Food Environment Pathways in Three Independent Study Samples.  45:798-810. 2022

Prolonged Glycemic Adaptation Following Transition From a Low-to High-Carbohydrate Diet: A Randomized Controlled Feeding Trial.  45:576-584. 2022

Does the Association Between Hemoglobin A1c and Risk of Cardiovascular Events Vary by Residential Segregation? The REasons for Geographic And Racial Differences in Stroke (REGARDS) Study.  44:1151-1158. 2021

Relation of lipoprotein(a) levels to incident type 2 diabetes and modification by alirocumab treatment.  44:1219-1227. 2021

Continuous Glucose Monitoring in the Operating Room and Cardiac Intensive Care Unit..  44:e50-e52. 2021

Association of Baseline Characteristics With Insulin Sensitivity and β-Cell Function in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study Cohort.  44:340-349. 2021

Severe Hypoglycemia, Cardiac Structure and Function, and Risk of Cardiovascular Events Among Older Adults With Diabetes.  44:248-254. 2021

Within-Trial Cost-Effectiveness of a Structured Lifestyle Intervention in Adults With Overweight/Obesity and Type 2 Diabetes: Results From the Action for Health in Diabetes (Look AHEAD) Study.  44:67-74. 2021

A shift toward a plant-centered diet from young to middle adulthood and subsequent risk of type 2 diabetes and weight gain: The coronary artery risk development in young adults (cardia) study.  43:2796-2803. 2020

Efficacy and safety of liraglutide 3.0 mg in individuals with overweight or obesity and type 2 diabetes treated with basal insulin: The SCALE insulin randomized controlled trial.  43:1085-1093. 2020

Optimization of metformin in the GRADE cohort: Effect on glycemia and body weight.  43:940-947. 2020

Genetic discrimination between LADA and childhood-onset type 1 diabetes within the MHC.  43:418-425. 2020

Prediabetes and risk for cardiovascular disease by hypertension status in black adults: The Jackson Heart Study.  42:2322-2329. 2019

Does the association of diabetes with stroke risk differ by age, race, and sex? Results from the reasons for geographic and racial differences in stroke (REGARDS) study.  42:1966-1972. 2019

Testosterone therapy in men with hypogonadism prevents progression from prediabetes to type 2 diabetes: Eight-year data from a registry study.  42:1104-1111. 2019

Risk factors for kidney disease in type 1 diabetes.  42:883-890. 2019

Type 1 diabetes risk in African-ancestry participants and utility of an ancestry-specific genetic risk score.  42:406-415. 2019

Nutrition therapy for adults with diabetes or prediabetes: A consensus report.  42:731-754. 2019

Impact of peer support on acute care visits and hospitalizations for individuals with diabetes and depressive symptoms: A cluster-randomized controlled trial.  41:2463-2470. 2018

A comparison of the 2017 American College of Cardiology/American Heart Association blood pressure guideline and the 2017 American diabetes association diabetes and hypertension position statement for U.S. adults with diabetes.  41:2322-2329. 2018

First genome-wide association study of latent autoimmune diabetes in adults reveals novel insights linking immune and metabolic diabetes.  41:2396-2403. 2018

A low-fat dietary pattern and diabetes: A secondary analysis from the women's health initiative dietary modification trial.  41:680-687. 2018

Duration of diabetes and prediabetes during adulthood and subclinical atherosclerosis and cardiac dysfunction inmiddle age: The CARDIA study.  41:731-738. 2018

Professional Practice Committee: Standards of medical care in Diabetesd2018.  41:S3. 2018

Diabetes and hypertension: A position statement by the American diabetes association.  40:1273-1284. 2017

Cardiometabolic disease staging predicts effectiveness of weight-loss therapy to prevent type 2 diabetes: Pooled results from phase III clinical trials assessing phentermine/topiramate extended release.  40:856-862. 2017

Update and next steps for real-world translation of interventions for type 2 diabetes prevention: Reflections from a diabetes care editors' expert forum. Diabetes care 2016;39:1186-1201.  40:e21-e22. 2017

Natriuretic peptide and high-sensitivity troponin for cardiovascular risk prediction in diabetes: The Atherosclerosis Risk in Communities (ARIC) study.  39:677-685. 2016

Erratum: Consequences of comorbidity of elevated stress and/or depressive symptoms and incident cardiovascular outcomes in diabetes: Results from the REasons for Geographic and Racial Differences in Stroke (REGARDS) study (Diabetes care (2016) 39 (101-109)).  39:495. 2016

Racial differences in the performance of existing risk prediction models for incident type 2 diabetes: The CARDIA study.  39:285-291. 2016

Ablation of the duodenal mucosa as a strategy for glycemic control in type 2diabetes: Role of nutrient signaling or simple weight loss.  39:2108-2110. 2016

Consequences of Comorbidity of Elevated Stress and/or Depressive Symptoms and Incident Cardiovascular Outcomes in Diabetes: Results from the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.  39:101-109. 2016

Cross-sectional and longitudinal associations between objectively measured sedentary time and metabolic Disease: The coronary artery risk development in young adults (CARDIA) Study.  38:1835-1843. 2015

Advances in the science, treatment, and prevention of the disease of obesity: Ref lections from a diabetes care editors' expert forum.  38:1567-1582. 2015

Improving Adiponectin Levels in Individuals With Diabetes and Obesity: Insights From Look AHEAD..  38:1544-1550. 2015

Arsenic exposure, arsenic metabolism, and incident diabetes in the strong heart study.  38:620-627. 2015

Mild gestational diabetes mellitus and long-term child health.  38:445-452. 2015

Hemoglobin a1c and the progression of coronary artery calcification among adults without diabetes.  38:66-71. 2015

The cross-sectional and longitudinal associations of diabetic retinopathy with cognitive function and brain MRI findings: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.  37:3244-3252. 2014

Weight-loss therapy in type 2 diabetes: Effects of phentermine and topiramate extended release.  37:3309-3316. 2014

The look AHEAD trial: Bone loss at 4-year follow-up in type 2 diabetes.  37:2822-2829. 2014

Impact of intensive lifestyle intervention on depression and health-related quality of life in type 2 diabetes: the Look AHEAD Trial..  37:1544-1553. 2014

The pharmacogenetics of Type 2 Diabetes: A systematic review.  37:876-886. 2014

Diabetes in first-degree family members: A predictor of type 2 diabetes in 159 nonscreening alabama hemochromatosis probands with HFE C282Y homozygosity.  37:259-266. 2014

Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: The action for health in diabetes.  37:2548-2556. 2014

Metabolic syndrome, C-reactive protein, and mortality in U.S. blacks and whites: The reasons for geographic and racial differences in Stroke (REGARDS) study.  37:2284-2290. 2014

Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release.  37:912-921. 2014

Preventive measures for patients at risk for amputation from diabetes and peripheral arterial disease.  37. 2014

Ten nights of moderate hypoxia improves insulin sensitivity in obese humans.  37. 2014

Ten nights of moderate hypoxia improves insulin sensitivity in obese humans.  36. 2013

Response to comment on: Wing et al. Effect of intensive lifestyle intervention on sexual dysfunction in women with type 2 diabetes: Results from an ancillary look AHEAD study. Diabetes Care 2013;36:2937-2944.  36. 2013

Scientific statement: Socioecological determinants of prediabetes and type 2 diabetes.  36:2430-2439. 2013

Type 2 diabetes with partial lipodystrophy of the limbs: A new lipodystrophy phenotype.  36:2247-2253. 2013

Effect of intensive lifestyle intervention on sexual dysfunction inwomen with type 2 diabetes: Results from an ancillary look ahead study.  36:2937-2944. 2013

Awareness, treatment, and control of LDL cholesterol are lower among U.S. adults with undiagnosed diabetes versus diagnosed diabetes.  36:2734-2740. 2013

Duration of abdominal obesity beginning in young adulthood and incident diabetes throughmiddle age: The CARDIA study.  36:1241-1247. 2013

Four-year analysis of cardiovascular disease risk factors, depression symptoms, and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes..  36:1088-1094. 2013

Four-year change in cardiorespiratory fitnessandinfluenceonglycemiccontrol in adults with type 2 diabetes in a randomized trial: The look AHEAD trial.  36:1297-1303. 2013

Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: Impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans.  36:845-853. 2013

Association of electrocardiographically determined left ventricular mass with incident diabetes, 1985-1986 to 2010-2011.  36:645-647. 2013

Generic medications and blood pressure control in diabetic hypertensive subjects.  36:591-597. 2013

Association of prediabetes and diabetes with stroke symptoms: The reasons for geographic and racial differences in stroke (REGARDS) study.  35:1845-1852. 2012

Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease.  35:994-1001. 2012

Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: Post hoc epidemiologic analysis of the ACCORD trial.  35:787-793. 2012

Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations of maternal A1C and glucose with pregnancy outcomes..  35:574-580. 2012

Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program..  35:363-366. 2012

Insulin sensitizers may attenuate lean mass loss in older men with diabetes.  34:2381-2386. 2011

Effectiveness of lifestyle interventions for individuals with severe obesity and type 2 diabetes: results from the Look AHEAD trial..  34:2152-2157. 2011

Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes.  34:1481-1486. 2011

Are the 2005 dietary guidelines for Americans associated with reduced risk of type 2 diabetes and cardiometabolic risk factors? Twenty-year findings from the CARDIA study.  34:1183-1185. 2011

Lack of association between 25(OH)D levels and incident type 2 diabetes in older women.  34:628-634. 2011

Maternal glucose concentration during pregnancy predicts fat and lean mass of prepubertal offspring.  34:741-745. 2011

The relation of diabetes, impaired fasting blood glucose, and insulin resistance to left ventricular structure and function in African Americans: The Jackson heart study.  34:507-509. 2011

A 1-year lifestyle intervention for weight loss in individuals with type 2 diabetes reduces high C-reactive protein levels and identifies metabolic predictors of change: from the Look AHEAD (Action for Health in Diabetes) study..  33:2297-2303. 2010

Impact of A1C screening criterion on the diagnosis of pre-diabetes among U.S. adults.  33:2190-2195. 2010

Blood pressure control in diabetes: Temporal progress yet persistent racial disparities: National results from the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.  33:798-803. 2010

Prevalence and predictors of abnormal cardiovascular responses to exercise testing among individuals with type 2 diabetes: the Look AHEAD (Action for Health in Diabetes) study..  33:901-907. 2010

Comparison of A1C and fasting glucose criteria to diagnose diabetes among U.S. adults.  33:95-97. 2010

Prevalence and risk factors for urinary incontinence in overweight and obese diabetic women: Action for Health in Diabetes (Look AHEAD) study.  32:1391-1397. 2009

Association of 20-year changes in cardiorespiratory fitness with incident type 2 diabetes: The Coronary Artery Risk Development in Young Adults (CARDIA) fitness study.  32:1284-1288. 2009

Oxidative stress and insulin resistance: The Coronary Artery Risk Development in Young Adults study.  32:1302-1307. 2009

Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular rIsk factors the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial.  32:221-226. 2009

Biophysical correlates of cognition among depressed and nondepressed type 2 diabetic patients.  32:48-50. 2009

Physical activity may facilitate Diabetes prevention in Adolescents.  32:9-13. 2009

Risk factors related to inflammation and endothelial dysfunction in the dcct/edic cohort and their relationship with nephropathy and macrovascular complications.  31:2006-2012. 2008

Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose.  31:1007-1014. 2008

First evidence of genetic association between AKT2 and polycystic ovary syndrome.  31:2284-2287. 2008

Burden of comorbid medical conditions and quality of diabetes care.  30:2999-3004. 2007

Efonidipine simultaneously improves blood pressure, endothelial function, and metabolic parameters in nondiabetic patients with hypertension.  30:1605-1607. 2007

Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals with Type 2 Diabetes One-year results of the Look AHEAD trial.  30:1374-1383. 2007

Physical activity in U.S. adults with diabetes and at risk for developing diabetes, 2003.  30:203-209. 2007

Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the hemochromatosis and iron overload screening (HEIRS) study.  29:2084-2089. 2006

Additive beneficial effects of fenofibrate combined with candesartan in the treatment of hypertriglyceridemic hypertensive patients.  29:195-201. 2006

Are health care professionals advising patients with diabetes or at risk for developing diabetes to exercise more?.  29:543-548. 2006

Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S. 2000-2002.  28:1599-1603. 2005

Walking and type 2 diabetes.  28:1524-1525. 2005

Barriers to physical activity among predominantly low-income African-American patients with type 2 diabetes.  28:1209-1210. 2005

Epidemiology of ischemic stroke in patients with diabetes: The greater Cincinnati/Northern Kentucky stroke study.  28:355-359. 2005

Randomized effectiveness trial of a computer-assisted intervention to improve diabetes care.  28:33-39. 2005

Statin neuropathy masquerading as diabetic autoimmune polyneuropathy.  28:2082. 2005

Stockpiling of ovarian follicles and the response to rosiglitazone.  28:2333-2334. 2005

Effect of rosiglitazone versus insulin on the pancreatic β-cell function of subjects with type 2 diabetes.  27:2585-2589. 2004

Risk factors for metabolic syndrome: The Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985-2001.  27:2707-2715. 2004

Estimation of resting energy expenditure considering effects of race and diabetes status.  27:1405-1411. 2004

Critical Evaluation of Adult Treatment Panel III Criteria in Identifying Insulin Resistance with Dyslipidemia.  27:978-983. 2004

The Effect of Vitamin Therapy on the Progression of Corona Artery Atherosclerosis Varies by Haptoglobin Type in Postmenopausal Women.  27:925-930. 2004

C-Reactive Protein and Glycemic Control in Adults with Diabetes: Response to King et al. [23] (multiple letters).  27:637-638. 2004

Efficacy of Conversion from Bedtime NPH Insulin Injection to Once- or Twice-Daily Injections of Insulin Glargine in Type 1 Diabetic Patients Using Basal/Bolus Therapy [20].  27:632-633. 2004

Intrinsic motivation and glycemic control in adolescents with type I diabetes [3].  27:1517. 2004

A descriptive and comparative study of the prevalence of depressive and anxiety disorders in low-income adults with type 2 diabetes and other chronic illnesses.  26:2311-2317. 2003

Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: Studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort.  26:1439-1448. 2003

Erratum: Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes (Diabetes Care (2002) 25 (1033-1041)).  26:971. 2003

Serum lipoproteins in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications cohort: Associations with gender and glycemia.  26:810-818. 2003

Development of a prediction equation for insulin sensitivity from anthropometry and fasting insulin in prepubertal and early pubertal children.  25:1203-1210. 2002

Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial.  25:1033-1041. 2002

Oral contraceptive use and association with glucose, insulin, and diabetes in young adult women: the CARDIA Study. Coronary Artery Risk Development in Young Adults..  25:1027-1032. 2002

Effects of low birth weight on insulin resistance syndrome in Caucasian and African-American children.  24:2035-2042. 2001

Prevalence and risk factors of microalbuminuria in a cohort of African-American women with gestational diabetes.  24:1764-1769. 2001

Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders: The cardiovascular health study.  24:1233-1239. 2001

Bromocriptine: a novel approach to the treatment of type 2 diabetes..  23:1154-1161. 2000

Late-onset troglitazone-induced hepatic dysfunction [5].  23:128-129. 2000

The diabetes prevention program: Baseline characteristics of the randomized cohort.  23:1619-1629. 2000

Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome.  22:1310-1317. 1999

Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke.  22:1077-1083. 1999

Gastroparesis cured by gastrectomy [4].  22:1000-1001. 1999

Antidiabetic treatment trends in a cohort of elderly people with diabetes: The Cardiovascular Health Study, 1989-1997.  22:736-742. 1999

Diabetes and automobile crashes in the elderly: A population-based case- control study.  22:220-227. 1999

Multicenter randomized trial of a comprehensive prepared meal program in type 2 diabetes.  22:191-197. 1999

Troglitazone's effect on lipoprotein(a) levels [6].  22:859-860. 1999

Effect of postmenopausal hormone therapy on glucose and insulin concentrations.  21:1589-1595. 1998

Diabetes and accident insurance..  21:877-878. 1998

Prescription drug use and costs among diabetic patients in primary health care practices in Germany.  21:389-397. 1998

Metformin lowers lipoprotein(a) levels [1].  21:2028. 1998

Troglitazone interferes with gemfibrozil's lipid-lowering action [2].  21:2028-2029. 1998

Coronary artery disease in diabetic patients with lower-extremity arterial disease: Disease characteristics and survival: A report from the coronary artery surgery study (CASS) registry.  20:1381-1387. 1997

Increased prevalence of mitral valve prolapse in IDDM..  19:672. 1996

Nesidioblastosis causing reversal of insulin-dependent diabetes and development of hyperinsulinemic hypoglycemia.  18:1379-1380. 1995

Genes within the major histocompatibility complex predict NIDDM in African-American women in Alabama.  17:1491-1494. 1994

Glucose transport and NIDDM.  15:396-417. 1992

Microalbuminuria associated with diabetic neuropathy.  15:528-531. 1992

Epidemiology of childhood IDDM in U.S. Virgin Islands from 1979 to 1988: Evidence of an epidemic in early 1980s and variation by degree of racial admixture.  14:558-564. 1991

Cyclosporin therapy for prevention and cure of IDDM. Epidemiological perspective of benefits and risks.  13:776-784. 1990

Risk factors for gestational diabetes in black population.  13:1196-1201. 1990

Condylomata acuminata in IDDM..  11:295-296. 1988

Futility of predicting onset of type I diabetes mellitus..  10:788-789. 1987

Non-insulin-dependent diabetes (NIDDM) in a newly independent Pacific nation: The Republic of Kiribati.  7:409-415. 1984

Limitation of fasting plasma glucose for the diagnosis of diabetes mellitus.  4:556-558. 1981

Qualitative issues in developing educational diagnostic instruments and assessment procedures for diabetic patients.  4:468-475. 1981